Dutch Kidney Foundation

• The RENAL LIFECYCLE Trial: A RCT to Assess the Effect of Dapagliflozin on Renal and Cardiovascular Outcomes in Patients With Severe CKD

  Collaborator, Phase 3, Active, not recruiting, 1,750 people, 16 May 2022

• NCT03073018

  Collaborator, Phase 3, Completed, 864 people, 8 Mar 2017

• NCT00404456

  Collaborator, Phase 3, Completed, 40 people, 28 Nov 2006

• NCT00388661

  Collaborator, Phase 3, Completed, 68 people, 17 Oct 2006

Sources: clinicaltrials.gov

• Increased mTOR signaling secondary to a human ILK missense variant inhibits nephrogenesis with decreased metabolism

  15OKG18, 19 Sept 2025

• Targeted Apoptosis of Senescent Cells Restores Tissue Homeostasis in Response to Chemotoxicity and Aging

  15OP11, 23 Mar 2017

• The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis

  Grant E033, 14 Mar 2012

Sources: api.crossref.org

• Survival benefit of deceased donor kidney transplantation versus continued dialysis: international target trial emulation

  Grants or research support, 18 Sept 2026

Sources: pubmed.ncbi.nlm.nih.gov